利润表
ATYR PHARMA INC
ATYR
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
0.20 | 0.40 | 0.40 | 10.39 | - | 10.46 | 0.42 | - | - | - | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
0.20 | 0.40 | 0.40 | 10.39 | - | 10.46 | 0.42 | - | - | - | - |
|
营业费用
|
77.82 | 68.15 | 55.27 | 56.79 | 34.02 | 26.37 | 23.40 | 32.82 | 47.15 | 57.94 | 47.62 |
|
研发费用
|
60.22 | 54.37 | 42.29 | 42.81 | 23.26 | 17.29 | 14.05 | 20.39 | 30.07 | 42.85 | 34.50 |
|
销售、一般及行政费用
|
17.60 | 13.78 | 12.98 | 13.98 | 10.75 | 9.08 | 9.35 | 12.44 | 17.08 | 15.09 | 13.11 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-77.62 | -67.75 | -54.87 | -46.40 | -34.02 | -15.91 | -22.98 | -32.82 | -47.15 | -57.94 | -47.62 |
|
营业外收入
|
3.50 | 3.89 | 4.52 | 1.06 | 0.24 | -0.32 | -0.79 | -1.70 | -1.06 | -0.04 | - |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
- | - | - | - | - | - | - | -1.70 | -1.06 | 0.04 | -0.36 |
|
税前利润
|
-74.12 | -64.02 | -50.40 | -45.34 | -33.77 | -16.23 | -23.76 | -34.52 | -48.21 | -57.90 | -47.97 |
|
所得税费用
|
- | - | - | - | - | - | - | 0.00 | 0.00 | -0.05 | - |
|
少数股东损益
|
-0.01 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.16 | - | - | - | - |
|
净利润
|
-74.12 | -64.02 | -50.39 | -45.34 | -33.77 | -16.22 | -23.60 | -34.52 | -48.21 | -57.86 | -47.97 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-76.92 | -67.04 | -54.27 | -46.17 | -33.52 | -15.34 | -22.34 | -32.07 | -46.43 | -57.04 | -46.75 |
|
基本每股收益
|
-0.80 | -0.86 | -0.94 | -1.60 | - | - | - | - | - | - | - |
|
稀释每股收益
|
-0.80 | -0.86 | -0.94 | -1.60 | - | - | - | - | - | - | - |
|
加权平均股数
|
92.99 | 74.26 | 53.61 | 28.42 | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
92.99 | 74.26 | 53.61 | 28.42 | - | - | - | - | - | - | - |
|
综合收益
|
-74.09 | -63.99 | -50.03 | -45.51 | -33.99 | -16.23 | -23.58 | -34.46 | -48.25 | -57.76 | -48.14 |